Vaxinano
PrivateLast Round
Seed
Oct 29, 2024
Total Funding Raised
$7.09M
Company Overview
Vaxinano is a biotechnology company that develops prophylactic and therapeutic nasal vaccines intended to treat infectious diseases for human and animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vaxinano Comparables
Compare Vaxinano with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lovaltech | 80% | |
| POP Biotechnologies, Inc. | 78% | |
| Xanadu Bio | 78% |
Vaxinano Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 29, 2024 | ||||
| Grant | Jun 1, 2020 | ||||
| Seed | Jun 22, 2017 |
Key People
Founding team and executive leadership
Vaxinano Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agence Nationale de la Recherche | Grant |
| WiSeed | Seed |
| Bpifrance | Seed |
| TCD Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
$6.46M raised from Finorpa and Nord France Amorquage.
Vaxinano Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vaxinano's valuation, stock price, and market status.
Is Vaxinano a public or private company?
Vaxinano is a private company.
What is the current stock price of Vaxinano?
Vaxinano is a private company with no public stock price. No recent secondary market data is available.
How much is Vaxinano worth (valuation)?
Valuation information for Vaxinano is not publicly available.
Can I buy Vaxinano stock?
Vaxinano shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vaxinano's last funding round?
Vaxinano's most recent funding round was Series A on October 29, 2024.
Who are the main investors in Vaxinano?
Key investors in Vaxinano include WiSeed, TCD Capital.
Will Vaxinano IPO soon?
No public IPO plans have been announced for Vaxinano.
How can I track Vaxinano secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vaxinano's secondary market activity and sign up for updates.